Moreover, antibody-mediated neutralization of CCR4 or CCR4 deletion blocks iNKT cell migration to the lungs, thereby attenuating the airway hyperresponsiveness (AHR) induced in mice by pulmonary administration of antigen or αGalCer47–49. The gene discussed is CCR4; the disease is airway hyperresponsiveness.